These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22106227)

  • 1. Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women.
    Benaboud S; Tréluyer JM; Urien S; Blanche S; Bouazza N; Chappuy H; Rey E; Pannier E; Firtion G; Launay O; Hirt D
    Antimicrob Agents Chemother; 2012 Feb; 56(2):776-82. PubMed ID: 22106227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women.
    Benaboud S; Hirt D; Launay O; Pannier E; Firtion G; Rey E; Bouazza N; Foissac F; Chappuy H; Urien S; Tréluyer JM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):857-62. PubMed ID: 22123690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women.
    Mandelbrot L; Peytavin G; Firtion G; Farinotti R
    Am J Obstet Gynecol; 2001 Jan; 184(2):153-8. PubMed ID: 11174495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonates.
    Hirt D; Urien S; Rey E; Arrivé E; Ekouévi DK; Coffié P; Leang SK; Lalsab S; Avit D; Nerrienet E; McIntyre J; Blanche S; Dabis F; Tréluyer JM
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1067-73. PubMed ID: 19104016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the fetal compartment (placenta and amniotic fluid).
    Else LJ; Taylor S; Back DJ; Khoo SH
    Antivir Ther; 2011; 16(8):1139-47. PubMed ID: 22155898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of lamivudine.
    Johnson MA; Moore KH; Yuen GJ; Bye A; Pakes GE
    Clin Pharmacokinet; 1999 Jan; 36(1):41-66. PubMed ID: 9989342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?
    Bouazza N; Hirt D; Bardin C; Diagbouga S; Nacro B; Hien H; Zoure E; Rouet F; Ouiminga A; Blanche S; Van De Perre P; Tréluyer JM; Msellati P; Urien S
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3280-6. PubMed ID: 20516271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samples.
    Hirt D; Urien S; Jullien V; Firtion G; Chappuy H; Rey E; Pons G; Mandelbrot L; Treluyer JM
    Br J Clin Pharmacol; 2007 Nov; 64(5):634-44. PubMed ID: 17892516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.
    Jullien V; Tréluyer JM; Rey E; Jaffray P; Krivine A; Moachon L; Lillo-Le Louet A; Lescoat A; Dupin N; Salmon D; Pons G; Urien S
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3361-6. PubMed ID: 16048948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women.
    Yeh RF; Rezk NL; Kashuba AD; Dumond JB; Tappouni HL; Tien HC; Chen YC; Vourvahis M; Horton AL; Fiscus SA; Patterson KB
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2367-74. PubMed ID: 19307360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.
    Chappuy H; Tréluyer JM; Jullien V; Dimet J; Rey E; Fouché M; Firtion G; Pons G; Mandelbrot L
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4332-6. PubMed ID: 15504861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.
    Bennetto-Hood C; Bryson YJ; Stek A; King JR; Mirochnick M; Acosta EP
    HIV Clin Trials; 2009; 10(1):41-7. PubMed ID: 19362995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens.
    Tuntland T; Odinecs A; Nosbisch C; Unadkat JD
    J Pharmacol Exp Ther; 1998 Apr; 285(1):54-62. PubMed ID: 9535994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.
    Benaboud S; Ekouévi DK; Urien S; Rey E; Arrivé E; Blanche S; Gray G; Sim KL; Avit D; McIntyre J; Nerrienet E; Dabis F; Tréluyer JM; Hirt D;
    Antimicrob Agents Chemother; 2011 Jan; 55(1):331-7. PubMed ID: 20956588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353.
    Bryson YJ; Mirochnick M; Stek A; Mofenson LM; Connor J; Capparelli E; Watts DH; Huang S; Hughes MD; Kaiser K; Purdue L; Asfaw Y; Keller M; Smith E;
    HIV Clin Trials; 2008; 9(2):115-25. PubMed ID: 18474496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment.
    Fauchet F; Treluyer JM; Illamola SM; Pressiat C; Lui G; Valade E; Mandelbrot L; Lechedanec J; Delmas S; Blanche S; Warszawski J; Urien S; Tubiana R; Hirt D
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5727-35. PubMed ID: 26149996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental pharmacokinetics of lamivudine in 580 pediatric patients ranging from neonates to adolescents.
    Bouazza N; Hirt D; Blanche S; Frange P; Rey E; Tréluyer JM; Urien S
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3498-504. PubMed ID: 21576443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section.
    Gonçalves PVB; Moreira FL; Benzi JRL; Duarte G; Lanchote VL
    J Clin Pharmacol; 2020 Dec; 60(12):1655-1661. PubMed ID: 32562572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
    Mirochnick M; Best BM; Stek AM; Capparelli EV; Hu C; Burchett SK; Rossi SS; Hawkins E; Basar M; Smith E; Read JS;
    J Acquir Immune Defic Syndr; 2011 Apr; 56(5):412-9. PubMed ID: 21283017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.
    Wade NA; Unadkat JD; Huang S; Shapiro DE; Mathias A; Yasin S; Ciupak G; Watts DH; Delke I; Rathore M; Hitti J; Frenkel L; Samelson R; Smith ME; Mofenson L; Burchett SK
    J Infect Dis; 2004 Dec; 190(12):2167-74. PubMed ID: 15551216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.